Sesen Bio
researches, discovers, develops and commercializes antibody-drug conjugate therapies for the treatment of cancer... Read moreSesen Bio
researches, discovers, develops and commercializes antibody-drug conjugate therapies for the treatment of cancer... Read more
2008
PublicMerged with Carisma Therapeutics, Inc.NASDAQSESN
News
Nov 13, 2025
Owler
Sesen Bio, Inc.: Sesen Bio's revenue changed from $19.96M in Mar 2025 to $59.75M in Sep 2025
May 14, 2025
Owler
Sesen Bio, Inc.: Sesen Bio's revenue changed from $19.63M in Dec 2024 to $19.96M in Mar 2025
Nov 08, 2024
Owler
Sesen Bio, Inc.: Sesen Bio's revenue changed from $20.71M in Jun 2024 to $20.27M in Sep 2024
May 10, 2024
Owler
Sesen Bio, Inc.: Sesen Bio's revenue changed from $14.92M in Dec 2023 to $15.07M in Mar 2024
Nov 10, 2023
Owler
Sesen Bio, Inc.: Sesen Bio's revenue changed from $49.04M in Jun 2023 to $50.63M in Sep 2023
Aug 11, 2023
Owler
Sesen Bio, Inc.: Sesen Bio's revenue changed from $49.79M in Mar 2023 to $49.04M in Jun 2023
May 11, 2023
Owler
Sesen Bio, Inc.: Sesen Bio's revenue changed from $57.78M in Sep 2022 to $49.79M in Mar 2023
Mar 08, 2023
Citybizlist
Sesen Bio: Carisma Therapeutics Closes Merger with Sesen Bio
Mar 06, 2023
MarketScreener
Sesen Bio: Sesen Bio : Asset Purchase Agreement - Form 8-K
Mar 04, 2023
Americanbankingnews
Sesen Bio: Sesen Bio, Inc. to Post FY2027 Earnings of ($0.03) Per Share, Jefferies Financial Group Forecasts (NASDAQ:SESN)
Sesen Bio Competitors
1
2
3
4
5
6
7
8
9
10